Medical treatment in China

CAR-T

CAR-T therapy generally begins with leukapheresis to obtain autologous T cells; under experimental conditions, a chimeric antigen receptor is introduced via a vector, enabling them to recognize specific tumor antigens. After quality release, a short course of lymphodepletion therapy is usually give…